Hatice Kübra Konca

Hatice Kübra Konca

Auto-generated profile, based on publicly available information

Hatice Kübra Konca

Department of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2023 in Turkish Journal of Pediatric Disease
Verified
Journal Article
Open access
PDF file
UAUfuk Ateş
Ufuk Ateş
EEErgun Ergün
Ergun Ergün
AQAnar Qurbanov
Anar Qurbanov
PKPari Khali̇lova
Pari Khali̇lova
SSSümeyye Sözduyar
Sümeyye Sözduyar
GBGülnur Göllü Bahadir
Gülnur Göllü Bahadir
Amaç: Bu çalışmanın amacı, çocukluk çağı ampiyeminde iki port tekniği ile video yardımlı torakoskopik cerrahinin (VATS) etkinlik, güvenlikve uygulanabilirliğini belirlemektir.Gereç ve Yöntemler: Çalışmaya 17 yaş altı 34 hasta dahil edildi. Hastaların demografik ve klinik verileri geriye dönük olarak kaydedildi.Bulgular: Çalışmaya 17 yaş altı 34 hasta dahil edildi. Şikayetlerin ilk başladığı gün 12 gündü. Hastaların şikayetleri başladıktan ortalama12 (2-46) gün sonra VATS uygulandı. Ampiyem 21 çocukta sağ hemitoraksta, 11 çocukta sol taraftaydı. İki hastaya bilateral dekortikasyonuygulandı. Drenaj için takılan göğüs tüpünün çıkarılma süresi ortalama 9.70 (2-26) gündü. Ameliyat sonrası kalış süresi 23.50 (4-120) güniken, toplam hastanede kalış süresi 32.50 (7-142) gündü. Takipler sırasında 7 hastada amfizem gelişti. Bir hastaya göğüs tüpü revizyonuyapıldı. 6 hastada spontan geriledi. İki çocuk solunum arresti ve karaciğer nakli sonrası torakoskopi dışı nedenlerden exitus oldu.Sonuç: VATS, çocuklarda plevral ampiyemde sonuçları iyi olan, uygulanabilir bir yöntemdir. Sonuçlar hastalığın erken veya geç dönemindetatmin edicidir.

9 January 2023 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
SDSeda Hançerli Demirbaş
Seda Hançerli Demirbaş
HOHalil Ozdemir
Halil Ozdemir
ŞYŞükriye Yılmaz
Şükriye Yılmaz
GAGul Arga
Gul Arga
HKHatice Kübra Konca
Hatice Kübra Konca
EÇErgin Çiftçi
Ergin Çiftçi
The current study aimed to investigate the clinical, laboratory and radiological findings of the pneumonia cases in children that were confirmed as M.pneumoniae by polymerase chain reaction (PCR) testing and to reveal the factors that can be decisive in the diagnosis. Seventy-seven children were included in this study. The median age of the patients was 31 months (1 month-17 years 4 months). The 63.6% of the patients were younger than five years of age, 53.2% were girls and 46.8% were boys. During the eight-year research period, the frequency of M.pneumoniae in the patients hospitalized with the diagnosis of pneumonia was found to be 3.1%. The rate of M.pneumoniae as the underlying factor of pneumonia was found to be statistically significantly lower in patients aged 0-60 months compared to the patients aged 61-216 months. In patients with M.pneumoniae accompanied by viruses, the age group was more likely to between 0-60 months. The most common symptoms were cough (96.1%) and fever (74%). Physical examinations revealed that 70.1% of the patients had rales, 63.6% had tachypnea, 45.5% had oropharyngeal hyperaemia, 35.1% had subcostal-intercostal retraction, 31.2% had long expiration period, 26% had rhonchus, 24.7% had decrease in breath sounds, 15.6% had cervical lymphadenopathy, 13% had tachycardia, 3.9% had otitis media, 3.9% had tonsil hypertrophy and 2.6% had a maculopapular rash. The rate of hypoxemia was found to be 42.2%. When the physical examination findings of patients with only M.pneumoniae detected in multiplex PCR analysis and those with accompanying viruses in M.pneumoniae were compared, tachypnea, oropharyngeal hyperemia and decreased breath sounds were found to be statistically significantly higher in patients with M.pneumoniae only. Retraction was detected more frequently in patients with accompanying viruses. When the laboratory results of the patients were evaluated according to age, leukocytosis was detected in only 18.2% of the patients, while the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were found to be high in 75% and 85.7% of the patients, respectively. In the multiplex PCR analysis, the CRP values of the patients with only M.pneumoniae were found to be higher than the patients with accompanying viruses. M.pneumoniae was accompanied by viruses at the rate of 40.3%. The most common accompanying viruses were rhinovirus, adenovirus, bocavirus and metapneumovirus. The 55.8% of the patients had lobar-segmental consolidation, 46.8% had parahilar-peribronchial thickening, 18.2% had atelectasis, 11.7% had pleural effusion, 9.1% had increase in reticulonodular density, 6.5% had lymphadenopathy whereas no abnormality was observed in 5.2% of them. No diffuse interstitial involvement was recorded. The CRP value of the patients who had lobar segmental consolidation which was detected through chest X-rays were statistically higher than those without consolidation. In multiplex PCR analysis, the rate of parahilar-peribronchial thickening detected in chest X-ray findings was found to be higher in patients with M.pneumoniae accompanied by viruses compared to those with only M.pneumoniae. The rate of the patients who were given empirical antibiotics against atypical agents was 45.5%. The rate of empirically administered antibiotic treatment for atypical agents after being hospitalization was higher in patients diagnosed with only M.pneumoniae compared to patients with M.pneumoniae and viruses. One patient (1.3%) died. As there are no typical clinical, laboratory or radiological findings specific to M.pneumoniae pneumonia, all of the findings should be assessed as a whole to establish a diagnosis. Besides, for the detection of M.pneumoniae, diagnostic tests which are cost effective, with rapid results and are capable of distinguishing colonisation from active infection should be developed.

13 February 2024 in Clinical Imaging
Verified
Journal Article
Closed access
GBGülsüm İclal Bayhan
Gülsüm İclal Bayhan
NGNadide Başak Gülleroğlu
Nadide Başak Gülleroğlu
SÇSelin Çetin
Selin Çetin
TETuğba Erat
Tuğba Erat
SSSelin Yıldız Sametoğlu
Selin Yıldız Sametoğlu
BDBedia Dinç
Bedia Dinç

18 October 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
HOHalil Ozdemir
Halil Ozdemir
NDNihal Ekin Dağ
Nihal Ekin Dağ
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
HKHatice Kübra Konca
Hatice Kübra Konca
GAGul Arga
Gul Arga
EIErdal İnce
Erdal İnce
In Turkey, the seven-valent pneumococcal conjugated vaccine (PCV7) was included in the childhood national immunization programme in April 2008 and was replaced by the 13-valent pneumococcal conjugated vaccine (PCV13) in April 2011. In this retrospective, single-center study, it was aimed to determine the serotype distribution and antimicrobial resistance in Streptococcus pneumoniae isolates of pediatric patients with invasive pneumococcal disease (IPD) after the introduction of PVC7 and PVC13. Fifty pediatric patients diagnosed with meningitis and sepsis/bacteremia between October 2009 and October 2019 were included in the study. The pediatric patient group consisted of previously healthy patients diagnosed with meningitis and sepsis/bacteremia with S.pneumoniae isolated in their blood or cerebrospinal fluids. Patients with pneumonia-associated bacteremia and empyema were not included in the study. Serotyping of the isolates was performed by Quellung reaction using specific antisera (Statens Serum Institute, Denmark) and antibiotic (penicillin and ceftriaxone) susceptibility was determined by antibiotic gradient method based on Clinical Laboratory Standards Institute (CLSI) criteria. Of the children, 29 (58%) were boys and 21 (42%) were girls. The median age of the patients was 19 months (1 month-18 year). When the children under the age of five were evaluated, it was found that 30 (79%) patients were diagnosed with occult bacteremia/sepsis and 8 (21%) with meningitis. The overall annual incidence rate of IPD among the healthy children aged <5 years decreased significantly from 9.35/100000 to 0.83/100000 (p0.05). The most common serotypes detected in isolates were 19F, 23F, 7F, 31 and 24B. According to the minimum inhibitory concentration values of the isolates recovered from patients with meningitis, penicillin and ceftriaxone resistance rates were found as 43.9% and 9.8%, respectively. In conclusion, our study showed that there was a 91.1% decrease in the incidence of IPD in healthy children aged under five years after the implementation of PCV7 and PCV13. It was determined that while the rate of serotypes in vaccine content decreased, there was an increase in non-vaccine serotypes. In addition no significant change was observed in antibiotic resistance rates over the years.

15 July 2026 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SDSevliya Ocal Demir
Sevliya Ocal Demir
PEPınar Canizci Erdemli
Pınar Canizci Erdemli
ETEsra Cakmak Taskin
Esra Cakmak Taskin
AYAyşe Tekin Yılmaz
Ayşe Tekin Yılmaz
SSSemra Sen
Semra Sen
GAGülşen Akkoç
Gülşen Akkoç

30 July 2022 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
CTChakan Tsakir
Chakan Tsakir
HOHalil Ozdemir
Halil Ozdemir
GAGul Arga
Gul Arga
HKHatice Kübra Konca
Hatice Kübra Konca
ETEsra Çakmak Taşkın
Esra Çakmak Taşkın
EIErdal İnCe
Erdal İnCe
The aim of this single-center retrospective study was to determine the changes in the burden of all-cause pneumonia, bacterial pneumonia and empyema in children aged 0-18 years after the availability of 7-valent pneumococcal conjugated vaccine (PCV7) and 13-valent pneumococcal conjugated vaccine (PCV13) in our country. Children aged 0-18 years who were hospitalized with the diagnosis of pneumonia and treated in Ankara between January 1, 2006 and December 30, 2019 were included in the study. The burden of disease according to the years was calculated as follows: after determining the number of patients with all-cause pneumonia, bacterial pneumonia and the empyema who were admitted to the pediatric infectious diseases service, we divided those numbers to admission numbers to all outpatient clinics in that year as the ratio in 100 000. The years 2006-2007 were accepted as pre-vaccine period, 2009-2010 as PCV7 period and 2012-2019 as PCV13 period. As 2008 and 2011 were the years when PCV7 and PCV13 vaccines implemented into the routine vaccination schedule, they were accepted as transition years and the patient data from these years were not used. All of the patients data were obtained from the patient files. There was a significant decrease in the disease burden of all-cause pneumonia in 0-18 years age and 0-24 months age group after PCV13 period compared to PCV7 period (p<0.001 and p<0.001). A statistically significant decrease was found in all-cause pneumonia among children older than 60 months after PCV13 period compared to PCV7 period and pre-vaccine period (p<0.05 and p<0.01, respectively). When pre-PCV13 (PCV7 and pre-vaccine periods together) and post-PCV13 periods were compared; in 0-18 years age, 0-24 months age and 24-60 months age groups, there was a significant decrease in the burden of disease due to all-cause pneumonia after PCV13 (p<0.001, p<0.001 and p<0.05) period. When the bacterial pneumonia disease burden in PCV13 period was evaluated, bacterial pneumonia disease burden in 0-18 years and 0-24 months age group was found to be significantly lower than in both pre-vaccine and PCV7 periods (p<0.001 and p<0.001). After PCV13 vaccine, the disease burden due to bacterial pneumonia was found to be significantly lower in 0-18 years age, 0-24 months age and older than 60 months age groups compared to pre-PCV13 period (p<0.001, p<0.001 and p<0.01). When PCV7 and PCV13 periods were compared in 0-18 years age group, a significant decrease was found in hospitalizations due to empyema after PCV13 (p<0.05). In conclusion, PCV7 and PCV13 led to a significant reduction in the incidence of all-cause pneumonia and bacterial pneumonia in children.